BackSyndax Pharmaceuticals Overview
Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals Target Price

Where could SNDX trade next? Consensus target price: $38.

Get informed when a big investor buys or sells

+ Follow

Share Price

$19.92

Average Target Price

$38.4092.8% upside

5 analysts in the last 4 months

High: $46 | Low: $31

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-05H.C. Wainwright$3890.8% upsideOpen
2026-06-12GuggenheimBrad Canino$3155.7% upsideOpen
2026-06-03H.C. WainwrightAndres Maldonado$40100.9% upsideOpen
2026-05-04Stifel Nicolaus$46131% upsideOpen
2026-05-01Barclays$3785.8% upsideOpen
2026-02-27Stifel NicolausStephen Willey$45126% upsideOpen
2025-11-24Barclays$3575.7% upsideOpen
2025-11-04UBS$3890.8% upsideOpen
2025-11-04BarclaysPeter Lawson$2210.5% upsideOpen
2025-09-10Stifel Nicolaus$44120.9% upsideOpen
2025-07-15UBSDavid Dai$3575.7% upsideOpen
2025-07-10Goldman SachsCorinne Johnson$189.6% downsideOpen
2024-11-13ScotiabankGeorge Farmer$189.6% downsideOpen
2024-10-24UBSDavid Dai$3785.8% upsideOpen
2024-08-15CitigroupYigal Nochomovitz$3470.7% upsideOpen
2024-08-15Bank of America SecuritiesJason Zemansky$3155.7% upsideOpen
2024-08-15BarclaysPeter Lawson$3365.7% upsideOpen
2024-07-30Bank of America SecuritiesJason Zemansky$3050.6% upsideOpen
2024-06-28JefferiesKelly Shi$3785.8% upsideOpen
2024-05-09Stifel NicolausBradley Canino$40100.9% upsideOpen
2023-01-03J.P. Morgan$41105.9% upsideOpen
2022-12-12Goldman Sachs$3995.8% upsideOpen
2022-12-12H.C. Wainwright$3365.7% upsideOpen

Syndax Pharmaceuticals (SNDX) FAQ

Syndax Pharmaceuticals (SNDX) currently reports a target price of $38. Use the charts on this page to explore Syndax Pharmaceuticals's target price history and peer comparisons.

Analysts' average 12-month price target for Syndax Pharmaceuticals is $38, about 92.8% upside from the current share price of $19.92. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $38, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Syndax Pharmaceuticals, and consider following SNDX for alerts when major investors trade the stock.

Syndax Pharmaceuticals is classified in the Healthcare sector. On target price, it currently shows $38. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SNDX with unrelated industries.